Lupin Limited
LUPIN
株式のランク
#2106
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
株価
$21.39
時価総額
$9.78B
変化（1日）
-0.07%
変化（1年）
-3.08%
国
IN
取引 Lupin Limited (LUPIN)
カテゴリー
Healthcare
Lupin Limited（LUPIN）の配当利回りの履歴
Lupin Limited（銘柄コード: LUPIN）の配当利回り（TTM）は2024-03-31時点で0.25%です。
過去5年間の平均配当利回り: 0.55%
過去5年間の平均配当利回り: 0.55%
Lupin Limited（LUPIN）の2004から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 0.91% | 121.95% |
| 2025 | 0.41% | 64.00% |
| 2024 | 0.25% | -59.68% |
| 2023 | 0.62% | -28.74% |
| 2022 | 0.87% | 47.46% |
| 2021 | 0.59% | -30.59% |
| 2020 | 0.85% | 30.77% |
| 2019 | 0.65% | -32.29% |
| 2018 | 0.96% | 84.62% |
| 2017 | 0.52% | 1.96% |
| 2016 | 0.51% | 240.00% |
| 2015 | 0.15% | -80.52% |
| 2014 | 0.77% | 50.98% |
| 2013 | 0.51% | -15.00% |
| 2012 | 0.60% | -9.09% |
| 2011 | 0.66% | -26.67% |
| 2010 | 0.90% | -48.28% |
| 2009 | 1.74% | 48.72% |
| 2008 | 1.17% | 116.67% |
| 2007 | 0.54% | -26.03% |
| 2006 | 0.73% | -45.52% |
| 2005 | 1.34% | 54.02% |
| 2004 | 0.87% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
